Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Effect of Whey Protein Supplementation on Inflammatory and Antioxidant Markers, and Clinical Prognosis in Acute Ischemic Stroke (Tns Trial): A Randomized, Double Blind, Controlled, Clinical Trial Publisher



Hashemilar M1, 2 ; Khalili M2, 3 ; Rezaeimanesh N3 ; Hokmabadi ES1, 2 ; Rasulzade S1, 2 ; Shamshirgaran SM4 ; Taheraghdam A1, 2 ; Farhoudi M1, 2 ; Shaafi S1, 2 ; Shakouri SK5 ; Osgouei DS1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Neurology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
  2. 2. Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  3. 3. Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Healthy Aging Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran
  5. 5. Physical Medicine and Rehabilitation Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Source: Advanced Pharmaceutical Bulletin Published:2020


Abstract

Purpose: Malnutrition is extensively prevalent amongst critically ill patients afflicted by ischemic stroke (IS). This study purpose was to evaluate the protein whey effect on inflammatory and antioxidant markers and functional prognosis in acute IS patients. Methods: Out of 42 patients with acute IS who were referred to Imam Reza Educational Hospital, Tabriz, Iran, 40 patients participated in the study. Twenty-one patients as control group received the hospital routine formula, and 19 patients as intervention group received 20 g/daily of whey protein through oral gavage. Inflammation and oxidative stress indicators (e.g., albumin, malondialdehyde (MDA), total antioxidant capacity (TAC), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), and high sensitivity C reactive protein (hs-CRP)and clinical variables included in were evaluated using National Institutes of Health Stroke Scale (NIHSS) and modified Rankin Scale (MRS) during admission and also 3 weeks after intervention. Results: Whey protein supplementation significantly decreased the NIHSS and MRS scores, TNF-α, IL-6, and hs-CRP by passing 3 weeks from intervention (P < 0.05). However, whey formula had no significant effect on other markers including albumin, and MDA. The hs-CRP (P = 0.02) reduction was significantly higher in whey protein group in comparison with control group. Conclusion: Whey protein supplementation reduced inflammation markers in those patients with IS. However, these changes should be studied in larger-scale trials. © 2020 The Author (s).